Recommendations on patient prioritization for outpatient Anti-SARS-CoV-2 therapies or preventive strategies when there are logistical or supply constraints.

The COVID-19 Treatment Guidelines Panel’s Interim Statement on Patient Prioritization for Outpatient Anti-SARS-CoV-2 Therapies or Preventive Strategies When There Are Logistical or Supply Constraints – COVID-19 Treatment Guidelines Panel

Commentary on Twitter

The rise in #Omicron infections may lead to supply constraints that limit the availability of anti-SARS-CoV-2 monoclonal antibodies or small molecule antivirals. We recommend prioritizing their use for patients at highest risk of clinical progression: https://t.co/IjcfP8AoOp

— NIH COVID-19 Treatment Guidelines (@NIHCOVIDTxGuide) December 27, 2021